News Feeds

Bio Screening Industry News

Selected Bio Screening news, events and internet recources.

deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme(TM) personal genome scan. Last update: 1:30 p.m. EDT Sept. 14, 2008 REYKJAVIK, Iceland, Sept 14, 2008 DCGN and colleagues at Radboud University Medical Center in the Netherlands today report the discovery of two common single-letter variants in the human [...] Colon Cancer Oncogene Discovered SUNDAY, Sept. 14 (HealthDay News) — Researchers have identified a new genetic player in the development of colon cancer. The findings implicate CDK8, a protein that regulates gene expression in the proliferation of colorectal cancer, the researchers found. Should the results be validated, they could lead to new therapeutic approaches for colon cancer, as well as new [...] TOCRIS SIGNS EXCLUSIVE DEAL TO SUPPLY GEFITINIB September 4th, 2008 - Tocris Bioscience announced today the signing of an exclusive deal with AstraZeneca to supply Gefitinib (also known as Iressa  and ZD1839) to preclinical researchers working on the mechanisms underlying cancer development. For the first time, scientists will be able to buy authentic, fully licensed, non-formulated Gefitinib as an off-the shelf product [...] New drug slows down cancer WA researchers have taken the first step towards developing new anti-cancer medications that could activate a gene shown to block the growth of cancerous cells. Led by Western Australian Institute for Medical Research (WAIMR) Director Professor Peter Klinken, the scientists have screened a large collection of drug-like molecules and recently identified a number of compounds which [...] AstraZeneca, Singapore institutions sign innovative new partnership to develop anti-cancer compounds Healthcare company AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) said Friday that it signed an innovative new partnership with the National Cancer Centre Singapore, or NCCS, and the National University Hospital, or NUH, for development of anti-cancer compounds. The [...] Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe Carlsbad, Calif., and Beltsville, Md., May 7, 2008 ? In research demonstrating that RNA previously thought to have no biological relevance may be of use for therapeutic and diagnostic targets, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and BioServe, the leading provider of clinically annotated tissue samples [...] Validated biomarkers will drive personalized medicine Biomarkers will be accepted as predicted tools, but their clinical usefulness needs to be understood first, according to personalized medicine expert. Coordinating personalized medicine on an international level, Dr Edward Abrahams, Executive Director of the Personalized Medicine Coalition believes that biomarkers will eventually impact all disease areas. ?When they were validated, and when it can be understood how clinically useful [...] Norwich company joins cancer fight A new company based on the Norwich Research Park has joined the fight against MRSA and cancer. Researchers at the John Innes Centre near Norwich have launched a new company, Inspiralis, based around their expertise in ‘DNA topoisomerases’. These are a group of enzymes that help DNA molecules to unravel and wind up properly and not to [...] DNA with a twist: New company to search for cancer drugs and antibiotics A new company has joined the fight against MRSA and cancer. Researchers at the John Innes Centre (Norwich) have launched a new company, Inspiralis Ltd, based around their expertise in DNA topoisomerases ? a group of enzymes that help DNA molecules to unravel and wind up properly and not to become tangled during replication. ?DNA becomes [...] New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left ‘homeless’ and they can’t survive on their own. The gene in question is called 14-3-3zeta and it can now be considered a potential target for selective anticancer drugs, according to Professor Haian [...] Michael J. Fox Foundation Awards $4.4 Million for Development of New Class of Parkinson?s Therapy NEW YORK, Dec. 18 /PRNewswire-USNewswire/ — The Michael J. Fox Foundation has awarded $4.4 million to jump-start the development of a new class of symptomatic Parkinson’s disease drugs targeting glutamate receptor mGluR4. The funding was awarded to a multidisciplinary team of researchers led by Jeffrey Conn, PhD, of Vanderbilt University under the Foundation’s LEAPS (Linked [...] Profiling of Tumor Tissue Slices is Awarded Prize Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest Rostock, Germany, November 26, 2007 / b3c newswire / - Bionas GmbH, a specialist for in vitro profiling the metabolic activity of cells, announced that Prof. Pedro Mestres of the Saarland University (Homburg/Saar, Germany) has been awarded [...] Gossypol Biological Properties Gossypol: is a polyphenolic aldehyde that permeates cells and acts as an inhibitor for several dehydrogenase enzymes. is antimalarial being the selective inhibitor of Plasmodium falciparum (pfLDH over hLDHs), an essential enzyme for energy generation within malarial parasite. posesses proapoptotic properties, probably due to the regulation of the Bax and Bcl2. reversibly inhibits Calcineurin and binds to calmodulin. inhibits replication [...] Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ — Strategic Diagnostics Inc. — today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI’s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com [...] BioServe and Phenomenome Discoveries Develop Novel Diagnostic Test for Colorectal Cancer Laurel, MD and Saskatoon, SK, Canada, August 6, 2007 ? BioServe and Phenomenome Discoveries Inc. (?PDI?) today announced that they have developed a novel serum-based diagnostic test for the identification of colorectal cancer (CRC), and pre-cancerous states conducive to the development of CRC. Colorectal cancer comprises a tenth of the global [...] Colorectal cancer research surges at Vanderbilt-Ingram Cancer Center The Vanderbilt-Ingram Cancer Center has landed another round of support for its Specialized Program of Research Excellence (SPORE) in gastrointestinal cancer, one of only five such programs in the country. The National Cancer Institute will provide $11.8 million over the next five years to forward Vanderbilt-Ingram’s innovative colorectal cancer research. “We received the top score in [...] BioServe Names Kevin Krenitsky as Chief Executive Officer Beltsville, MD, May 7, 2007 ? BioServe today strengthened its senior management team with the appointment of Kevin Krenitsky, M.D. as Chief Executive Officer.  Krenitsky is a highly respected 15-year veteran of the life sciences industry, bringing a wealth of experience in building and managing global biotechnology operations. ?Kevin?s impressive range of experience in diagnostics, pre-clinical [...] Canadian Cancer Society invests nearly $5-million in local researchers VANCOUVER, May 2 /CNW/ - The Canadian Cancer Society has awarded more than $4.8-million to nine cancer research projects in B.C. The Society’s total research investment across Canada in 2007-08 is over $47-million and includes 78 new grants. More than 500 research teams coast-to-coast are currently receiving funds from the Canadian Cancer Society. “Advances in research over the past few [...] EpiCept Corporation to Present at the 2007 BIO International Convention TARRYTOWN, N.Y., May 04, 2007 /PRNewswire-FirstCall/ — EpiCept Corporation today announced that the Company’s management will be making three presentations at the 2007 BIO International Convention, taking place May 6 through May 9, 2007 at the Boston Convention and Exhibition Center, Boston, MA. Jack Talley, President and CEO, will participate in a Breakout Session entitled, “Creative [...] Sensitive and Specific Biomarker for Early Detection of Prostate Cancer Identified Newswise ? Scientists at a Maryland-based pharmaceutical company have preliminary evidence showing that a protein in the blood may prove to be a biomarker that is more sensitive and specific than current methods of early detection for prostate cancer. If they?re right, the protein ? an enzyme called human aspartyl (asparaginyl) beta-hydroxylase, or HAAH ? could [...]